tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CFRX

CFRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsCFRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
CFRX
ContraFect files to sell $15M of common stock, Class E warrants
PremiumThe Fly
ContraFect files to sell $15M of common stock, Class E warrants
6M ago
CFRX
ContraFect files to sell 7.03M shares of common stock for holders
PremiumThe Fly
ContraFect files to sell 7.03M shares of common stock for holders
6M ago
CFRX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
ALDX
APLT
ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study
PremiumPress Releases
ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study
6M ago
CFRX
ContraFect announces FDA clearance of CF-370 IND application
PremiumThe FlyContraFect announces FDA clearance of CF-370 IND application
6M ago
CFRX
option delistings on September 25th
PremiumThe Fly
option delistings on September 25th
7M ago
MFH
NYC
ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development
PremiumPress Releases
ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development
7M ago
CFRX
ContraFect Announces Submission of IND Application to the FDA for its Development Candidate CF-370
PremiumPress Releases
ContraFect Announces Submission of IND Application to the FDA for its Development Candidate CF-370
7M ago
CFRX
ContraFect announces submission of IND application to FDA for CF-370
PremiumThe Fly
ContraFect announces submission of IND application to FDA for CF-370
7M ago
CFRX
ContraFect to Present at the World Anti-Microbial Resistance Congress 2023
PremiumPress Releases
ContraFect to Present at the World Anti-Microbial Resistance Congress 2023
8M ago
CFRX
ContraFect reports Q2 EPS ($1.94) vs ($36.79) last year
PremiumThe Fly
ContraFect reports Q2 EPS ($1.94) vs ($36.79) last year
8M ago
CFRX
ContraFect enters warrant exercise transaction for $9.6M in proceeds
PremiumThe FlyContraFect enters warrant exercise transaction for $9.6M in proceeds
10M ago
CFRX
ContraFect Enters Into a Warrant Exercise Transaction for Proceeds of $9.6 Million
PremiumPress Releases
ContraFect Enters Into a Warrant Exercise Transaction for Proceeds of $9.6 Million
10M ago
CFRX
ContraFect announces presentation of data at ASM Microbe 2023
PremiumThe Fly
ContraFect announces presentation of data at ASM Microbe 2023
10M ago
CFRX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
10M ago
CFRX
MRKR
ContraFect Gains with Key Data Presentation Set for Next Week
PremiumMarket News
ContraFect Gains with Key Data Presentation Set for Next Week
11M ago
CFRX
ContraFect to Present New Data Demonstrating the Potential Efficacy of Its Engineered Lysins Against Antibiotic-Resistant Pathogens at ASM Microbe 2023
PremiumPress Releases
ContraFect to Present New Data Demonstrating the Potential Efficacy of Its Engineered Lysins Against Antibiotic-Resistant Pathogens at ASM Microbe 2023
11M ago
CFRX
ContraFect Reports First Quarter 2023 Financial Results and Provides Business Update
PremiumPress Releases
ContraFect Reports First Quarter 2023 Financial Results and Provides Business Update
11M ago
CFRX
ContraFect announces first patient dosed in Phase 1b/2 study of exebacase
PremiumThe FlyContraFect announces first patient dosed in Phase 1b/2 study of exebacase
12M ago
CFRX
ContraFect Data Presentations at the 33rd Annual ECCMID Meeting Highlight the Potential Efficacy of Lysin CF-370 Against Antibiotic Resistant Gram-negative Pathogens
PremiumPress Releases
ContraFect Data Presentations at the 33rd Annual ECCMID Meeting Highlight the Potential Efficacy of Lysin CF-370 Against Antibiotic Resistant Gram-negative Pathogens
1y ago
CFRX
ContraFect presents CF-370 data at annual EECMID meeting
PremiumThe Fly
ContraFect presents CF-370 data at annual EECMID meeting
1y ago
CFRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >